EBV Capsid Antibody (VCA IgG): What a Positive, Negative or Equivocal Result Means

At a Glance

This measures IgG antibodies to the viral capsid antigen of Epstein-Barr virus — the protein shell of the virus — in a blood sample. You may see it written several ways on a report: EBV CAPSID Ag.Ab/IgG, antibody to viral capsid antigen, VCA IgG. They are the same test.

What it tells you is whether this virus has been met, now or previously. For most people the answer is yes. CDC: "Since over 90% of adults have been infected with EBV, most adults will show antibodies to EBV from infection years earlier." One manufacturer's validation found 93.4% of blood donors positive.

How to read your result

Your report gives a figure and a classification, and this test has three classifications rather than two.

The range stored on this record is 0 - 18 U/mL, and the thing to know about it is that it is not a target range. A boundary near 18 on this test is where a laboratory's negative classification ends, not where a healthy result sits.

One widely used version of this test, Labcorp's, publishes its classifications as negative below 18.0 U/mL, equivocal from 18.0 to 21.9, and positive above 21.9. Which assay produced any particular result is not recorded on this record, so those figures are an example of how a laboratory draws the line rather than a statement about your report — your own report's classification is the one that applies to you.

What the high mark on this record does and does not carry: a figure above the stored interval is marked high here, and that mark is a comparison with the interval stored on this record. It does not tell you which of the three classifications your laboratory assigned — that is printed on your report, and it is what applies to you. If your own report says positive, that is the common result on this test, since over 90% of adults are.

One caution that applies to every laboratory's version: the unit is an arbitrary concentration, which LOINC states explicitly, so no international standard sits behind U/mL for this test. Other laboratories report this analyte on entirely different scales, and the cutoff printed on your own report is the one that applies to your number.

What a positive result tells you

That you have been infected with EBV — currently or in the past. Laboratory documentation for this test describes the presence of VCA IgG as indicating past or current exposure, so it is not a past-infection marker alone, and that distinction matters if you are unwell now.

The timing is why. CDC: "Anti-VCA IgG appears in the acute phase of EBV infection, peaks at 2 to 4 weeks after onset, declines slightly then persists for the rest of a person's life." The antibody is already present during an acute infection — 2 to 4 weeks is when it peaks, not when it arrives — and then it never leaves. Most primary infections happen in childhood and many are silent, which is why people who never knowingly had mononucleosis test positive.

What an equivocal result tells you

That the test has not answered the question. An equivocal figure sits in the narrow band between the negative and positive cutoffs, and it cannot be read as an all-clear in either direction.

It is a normal outcome of any cutoff-based test: some values fall close enough to the threshold that the result cannot be called confidently. Guidance for this panel notes that repeat testing in 10 to 14 days may be helpful where results are equivocal — whether it is the right step depends on the clinical context, and a still-developing antibody response may or may not have moved by then. Reading the other EBV antibodies alongside it is the other half: VCA IgM and EBNA together place a result in a pattern this line cannot.

Why a lifelong antibody is not a measure of protection

A positive result does not mean your body cleared the virus. EBV is not eliminated. It establishes latency inside memory B cells, where, as the literature puts it, "the virus remains largely silent for the lifetime of the host."

What follows is a statement about this test rather than about immunity in general. This antibody documents exposure; it does not measure protective immunity and does not certify protection against EBV-related illness. Protection and persistent infection can coexist: a randomized EBV vaccine trial found roughly 78% efficacy against infectious mononucleosis while having no effect on whether people became infected. So lifelong infection does not make protection impossible — this number is simply not what would show it, either way.

Reading a high number

CDC, on EBV antibody levels: "High or elevated antibody levels may be present for years and are not diagnostic of recent infection."

What that establishes is narrow: a high value on its own cannot establish recent infection or reactivation. A high figure can sit unchanged for years.

What it does not say is that a high value never contributes. Read with the rest of the panel it can. CDC's primary-infection criteria include it: "Other results that strongly suggest a primary infection are a high or rising level of anti-VCA IgG and no antibody to EBNA after at least 4 weeks of illness." A high figure with absent EBNA, in someone ill for a month or more, points somewhere the single number does not.

And whether the height of the figure means anything depends on the assay. Some VCA IgG tests state that the numeric value above their cutoff does not indicate the amount of antibody present; others are calibrated quantitatively with a documented linear range. Your laboratory's documentation settles which you have.

If you remember only one thing

This virus has been met, as it has by over 90% of adults, and the antibody stays for life. The classification on your own report — negative, equivocal or positive — is the one that applies to you; the stored 0 - 18 here is not a target range and the high mark is not a classification. And a high value alone cannot establish recent infection or reactivation.

Two people, same result

Two people both get a capsid IgG of 95 U/mL, on the same assay, and both reports classify it as positive.

The first had the test on a general panel, feels well, and has no reason to think anything is wrong. For her it is the ordinary record of an EBV infection she may not remember — a positive on a test where over 90% of adults are positive.

The second has been unwell for weeks and was tested because a clinician is working through causes. For him the same positive is one line in an investigation — read with VCA IgM, with EBNA, and with the timeline of his illness. If EBNA is absent and he has been ill a month, that combination means something the number alone does not. It may equally turn out incidental.

The figure is identical. What differs is the question around it.

What this result cannot tell you

Whether the virus is active right now, from this line alone. CDC states elevated levels may be present for years without indicating recent infection. Read with the other antibodies, the panel can speak to current infection; this number cannot.

How recently you were infected. The antibody persists for life, so it carries no date.

Whether your symptoms are caused by EBV. With over 90% of adults carrying the virus, finding the antibody in someone with symptoms establishes nothing causal.

Whether you are protected from EBV-related illness. It documents exposure, not protective immunity.

Whether you have cancer. Some cancers are associated with EBV, but the screening programmes that exist use a different antibody class — IgA — and viral DNA, in defined high-risk populations. This antibody has not been validated as a cancer screen.

Common interpretation mistakes

Reading the stored 0 - 18 as a target range. A boundary near 18 is where a laboratory's negative classification ends. Most adults are positive on this test, so a figure above a negative cutoff is the ordinary finding.

Reading the high mark on this record as a classification. It is a comparison with the interval stored here, and which assay fed that interval is not documented. Negative, equivocal and positive come from your own report.

Reading a high value on its own as "active" or "recent". CDC states elevated levels may be present for years and are not diagnostic of recent infection.

Reading an equivocal result as a negative one. It establishes neither.

Comparing the number to a cutoff from elsewhere. The units are arbitrary, so a figure and a threshold only mean something together, on one report.

Assuming the size of the number carries meaning. Whether it does depends on whether your assay quantifies.

Questions your doctor may ask

Why was this test ordered, and what question was it meant to answer? Have you ever had diagnosed mononucleosis, and when? What symptoms prompted the test, and how long have they been present? Were VCA IgM and EBNA run at the same time, and what did they show? Anything affecting your immune system — a medication, a condition, a transplant? And what would change in your care depending on the answer?

Read together with

A single EBV antibody is not how this is read; the pattern across the panel carries the meaning.

VCA IgM is the short-lived antibody of acute infection, and its presence beside this one is the main thing separating a recent infection from an old one.

EBNA IgG arrives late. CDC: "The presence of antibodies to both VCA and EBNA suggests past infection (from several months to years earlier)." That combination is the clearest signature of an old infection. Its absence beside a high VCA IgG, after four weeks of illness, is what points the other way.

Early antigen (EA) IgG appears in the acute phase and is read with the others.

EBV DNA by PCR measures viral DNA rather than antibody. Its uses are selected ones — EBV-associated lymphoproliferative disease, risk after transplant, immunosuppressed patients — not a general answer to "is my EBV active". A low-copy positive "may not distinguish between clinically insignificant, latently infected cells and primary infection."

Clinical pearls

The stored interval is not a target range — a boundary near 18 marks the end of a laboratory's negative classification, and most adults are positive on this test. The record's high mark is a comparison with that interval, not the laboratory's classification.

An antibody that persists for life cannot date an infection.

Arbitrary units are central. U/mL is not standardized for this test, so a figure and its cutoff are a pair and neither crosses to another assay — this library holds the same analyte on four scales.

Equivocal is a third state, not a weak negative. Repeat testing may help, and may not resolve it.

Swapping antibody for viral DNA does not settle the activity question: a low-copy positive PCR may not distinguish latent infection from primary.

Clinical Takeaway

This is IgG to the Epstein-Barr virus capsid antigen, in serum, reported in arbitrary U/mL. The stored range 0 - 18 is not a target range: a boundary near 18 is where a laboratory's negative classification ends — Labcorp publishes negative below 18.0, equivocal 18.0 to 21.9, positive above 21.9, as one laboratory's example. Which assay produced a given result is not recorded here, so the high mark on this record compares the figure with the stored interval rather than classifying it; your own report's classification is what applies to you — and a positive one is the common case, as over 90% of adults are positive. A positive result indicates EBV infection past or current: the antibody appears in the acute phase and then "persists for the rest of a person's life". It does not measure protective immunity. Separately, EBV persists latently rather than being cleared. On a high value, "High or elevated antibody levels may be present for years and are not diagnostic of recent infection" — so the figure alone cannot establish recent infection or reactivation, though CDC includes a high or rising level with absent EBNA after four weeks of illness among patterns suggesting primary infection. An equivocal result establishes nothing in either direction; repeat testing may help, depending on the clinical context. Read it with the rest of the panel, against your own report's cutoff, and with whoever ordered it.

In one sentence

Evidence of Epstein-Barr virus infection, past or current, as in over 90% of adults — read against your own report's classification, never on its own.

Bottom line

If your report says positive and you feel well, that is the common state on this test. The high mark here only tells you the figure sits above the interval stored on this record, which is not a target range — read your own report for the classification. If you were tested because something is wrong, the number belongs inside that investigation alongside VCA IgM and EBNA, rather than at the end of it.